Articles related to INSOMNIA/SLEEP DISORDERS

Explore the complexities of diagnosing sleep disorders with this challenging case of a 72-year-old man. Your insights could reveal the underlying issue. Are you ready to put your expertise to the test?

This review sheds light on the complex role of daridorexant in treating insomnia, examining its potential suicidal risk and the need for more comprehensive data to completely understand its impact on mental health.

Unraveling the crucial role of sleep in the aftermath of sports-related concussions, a recent study underlines how the brain leverages sleep as a self-healing tool, hence emphasizing the clinical severity of such injuries and the potential implications for future treatment strategies.

Revolutionizing Sleep Apnea Diagnosis with Wearable Technology Tackling the increasing prevalence of sleep disorders like sleep apnea, Georgia Tech researchers have brought a paradigm shift in the field of sleep diagnostics. Their development of a wearable sleep monitor patch, characterized by its accuracy and comfort, offers the promise of a more accessible and cost-effective means of diagnosing sleep disorders, revolutionizing the way sleep medicine is practiced.

Insomnia is often underrecognized and undertreated in primary care settings. A panel of experts convened by Haymarket Medical Education emphasizes the importance of considering comorbid medical and psychiatric illnesses in patients with insomnia and recommends proactive screening and personalized treatment strategies. As a psychiatrist, neurologist, or other sleep disorder professional, you may often be on the front lines of managing insomnia, a condition that is increasingly prevalent yet remains underrecognized in primary care settings. A recent report by a panel of experts provides crucial insights and recommendations to enhance our approach to this pervasive sleep disorder:

The United States is currently experiencing a shortage of Adderall, a medication used to treat attention deficit disorder (ADD)/attention deficit hyperactivity disorder (ADHD) and narcolepsy. The FDA, in frequent communication with manufacturers, has not provided a clear timeline for when the shortage will be resolved. The shortage is attributed to various factors. The demand for Adderall has increased significantly, with a 10% rise in prescriptions filled in 2021 compared to the previous year. The US Drug Enforcement Agency’s efforts to combat prescription drug misuse have also played a role in limiting production. Furthermore, the pandemic led to the emergence of telemedicine startups, making it easier for individuals to obtain Adderall prescriptions, sometimes inaccurately. While waiting for the supply to be restored, healthcare professionals can consider alternative therapies such as dexmethylphenidate, methylphenidate, and dextroamphetamine.